Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
Year: 2015
Type: article
Study design: Clinical Trial
Source: The Lancet Respiratory Medicine
Authors: Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Carolina Fazio, Diego Annesi, Marica Lenoci, Giovanni Amato, Riccardo Danielli, Maresa Altomonte, Diana Giannarelli, Anna Maria Di Giacomo, Michele Maio
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: European Commission
OpenAlex ID: W2057312839
